Structure Therapeutics Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported net loss was USD 24.5 million compared to USD 11.88 million a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
39.16 USD | +7.64% | +9.75% | -3.39% |
05-21 | JPMorgan Starts Structure Therapeutics With Overweight Rating | MT |
05-09 | Structure Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.39% | 1.7B | |
+10.88% | 115B | |
+12.47% | 106B | |
-4.26% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-13.17% | 17.56B | |
-40.50% | 17.32B | |
+6.50% | 14.03B | |
+31.27% | 12.13B |
- Stock Market
- Equities
- GPCR Stock
- News Structure Therapeutics Inc.
- Structure Therapeutics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023